Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Brad H. Rovin's publication output changed over time?
ScholarIQpublication output · 1999–2023
Output grew0% over the shown period — from 1 works in 1999 to 1 in 2023.
1
1
1
1
1
1
2
3
1
199920052012201320162019202020212023
What are the most-cited papers on Brad H. Rovin?
ScholarIQmost cited works
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Lee A. Hebert, Samir M. Parikh, Jason Prosek, Tibor Nádasdy, Brad H. Rovin
American Journal of Nephrology. 20134,380 CitationsOPEN ACCESS
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege
Kidney International. 20212,475 CitationsOPEN ACCESS
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sánchez‐Guerrero, Romeo Maciuca, David Zhang, Jay Garg, Paul Brunetta, Gerald B. Appel, LUNAR Investigator Group
S132787887. 20121,454 Citations
The Influence of <i>CCL3L1</i> Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility
Enrique A. González, Hemant Kulkarni, Héctor Bolívar, Andrea Mangano, Racquel Sanchez, Gabriel Catano, Robert J. B. Nibbs, Barry I. Freedman, Marlon P. Quinones, Michael J. Bamshad, Krishna K. Murthy, Brad H. Rovin, William P. Bradley, Robert A. Clark, Stephanie A. Anderson, Robert J. O’Connell, Brian K. Agan, Seema S. Ahuja, Seema S. Ahuja, Rosa Bologna, Luisa Sen, Matthew J. Dolan, Sunil K. Ahuja, Sunil K. Ahuja
Science. 20051,142 Citations
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth
New England Journal of Medicine. 20201,005 CitationsOPEN ACCESS
Related on ScholarIQ
The Ohio State University Wexner Medical Center
Institution
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Paper
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Paper
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
Paper
The Influence of <i>CCL3L1</i> Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility
Paper
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Paper